+44 207 394 30 90 (London)

Major Investment Projects

Production of medicines in the form of sachets and high-tech biosimilars

Operator/initiator: JSC Nobel AFF

Stage: Development of design estimates and feasibility studies

Dates: 2022–2025

Investments: $55 mil

This company will promote the development of domestic production of original medicines and medical devices, increase the export potential of domestic pharmaceutical products, as well as increase scientific and human potential.

Creation of a biopharmaceutical complex for the development and production of modern medicines

Operator/initiator: LLP Research and Production Complex Bio-Eurasia

Location: Almaty

Investments: $63,978 mil

Within the framework of the project, it is planned to build a biopharmaceutical complex for the development and production of the following modern medicines: immunosuppressants, immunomodulators, antiviral, anticancer, anti-inflammatory, hormonal, antianemic preparations, blood substitutes, antihemophilic, anticholinergic medicines, anesthetics, antioxidants, cardiovascular and phlebological medicines.

Production of biotechnological products

Operator/initiator: Ministry of Health

Location: Almaty

Stage: Preparation of documentation

Dates: 2022–2025

Investments: $57.89 mil

Vaccine production

Operator/initiator: Ministry of Health of the Republic of Kazakhstan

Location: Almaty

Stage: Preparation of documentation

Dates: 2022–2023

Investments: $36.61 mil

Production of nonwoven fabric

Operator/initiator: LLP Merusar and K

Location: Pavlodar

Investments: $43,591 mil

The project involves the construction of a plant for the production of nonwoven fabric with a capacity of 10,000 tonnes annually. Nonwoven materials are widely used for the production of personal protective equipment, disposable medical masks, gowns, drapes, сoveralls, etc. The production will be localised in the free economic zone in Pavlodar.

Construction of a plant for the dialysers production

Operator/initiator: Ministry of Health of the Republic of Kazakhstan

Location: Aktobe region

Stage: Difficulties with project financing

Date: The commissioning was previously scheduled for 2021, now the launch has been postponed to 2024

Investments: $7.74 mil

It is expected that the production capacity will be 1 mil dialysers per year. It is noted that this project has no analogues in Kazakhstan and the CIS. German technologies will be used at the plant.

Request the full list of Investment Projects

    Please note that due to our internal policy we are not entitled to send any materials to personal emails (Yahoo, Yandex, Google, etc.)

    If you have any questions, please contact us:

    +44 207 394 3090 (London)

    Where did you hear about this event?